
Analgesics in the United Arab Emirates
Description
Analgesics in the United Arab Emirates
Value sales of analgesics in the United Arab Emirates continue to rise, with local consumers increasingly using analgesics to treat more than just conventional headaches or joint pain. In 2024, Panadol (GSK Consumer Healthcare) launched an advertising campaign in the United Arab Emirates, promoting its use for minor pains, such as bumps from furniture or even pre-emptively taking it before painful cosmetic treatments. Influential beauty bloggers are also sharing how they take Panadol before thre...
Euromonitor International's Analgesics in United Arab Emirates report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2019-2023, allowing you to identify the sectors driving growth. Forecasts to 2028 illustrate how the market is set to change.
Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.
Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.
Why buy this report?
* Get a detailed picture of the Analgesics market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.
Table of Contents
24 Pages
- Analgesics in the United Arab Emirates
- Euromonitor International
- September 2024
- List Of Contents And Tables
- ANALGESICS IN THE UNITED ARAB EMIRATES
- KEY DATA FINDINGS
- 2024 DEVELOPMENTS
- Expanding use of analgesics in the United Arab Emirates
- Rise in alternative therapies for chronic pain management
- 2023’s strong performing brands are now experiencing a slowdown in growth
- PROSPECTS AND OPPORTUNITIES
- Low penetration of paediatric analgesics in the local market
- Major price differential between regional and international players
- Panadol to maintain strong lead in systemic analgesics
- CATEGORY DATA
- Table 1 Sales of Analgesics by Category: Value 2019-2024
- Table 2 Sales of Analgesics by Category: % Value Growth 2019-2024
- Table 3 NBO Company Shares of Analgesics: % Value 2020-2024
- Table 4 LBN Brand Shares of Analgesics: % Value 2021-2024
- Table 5 Forecast Sales of Analgesics by Category: Value 2024-2029
- Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2024-2029
- CONSUMER HEALTH IN THE UNITED ARAB EMIRATES
- EXECUTIVE SUMMARY
- Consumer health in 2024: The big picture
- 2024 key trends
- Competitive landscape
- Retailing developments
- What next for consumer health?
- MARKET INDICATORS
- Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2019-2024
- Table 8 Life Expectancy at Birth 2019-2024
- MARKET DATA
- Table 9 Sales of Consumer Health by Category: Value 2019-2024
- Table 10 Sales of Consumer Health by Category: % Value Growth 2019-2024
- Table 11 NBO Company Shares of Consumer Health: % Value 2020-2024
- Table 12 LBN Brand Shares of Consumer Health: % Value 2021-2024
- Table 13 Penetration of Private Label in Consumer Health by Category: % Value 2019-2024
- Table 14 Distribution of Consumer Health by Format: % Value 2019-2024
- Table 15 Distribution of Consumer Health by Format and Category: % Value 2024
- Table 16 Forecast Sales of Consumer Health by Category: Value 2024-2029
- Table 17 Forecast Sales of Consumer Health by Category: % Value Growth 2024-2029
- APPENDIX
- OTC Registration And Classification
- Vitamins And Dietary Supplements Registration And Classification
- Self-medication/self-care And Preventive Medicine
- Switches
- DISCLAIMER
- DEFINITIONS
- SOURCES
- Summary 1 Research Sources
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.